Kretowski A - Search Results

1

Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumour necrosis factor-alpha in peripheral whole blood of people at high risk of developing type 1 diabetes and people with newly diagnosed type 1 diabetes.

Kretowski A, Myśliwiec J, Szelachowska M, Kinalski M, Kinalska I. Kretowski A, et al. Diabetes Res Clin Pract. 2000 Feb;47(2):81-6. doi: 10.1016/s0168-8227(99)00122-9. Diabetes Res Clin Pract. 2000. PMID: 10670906

2

[Influence of nicotinamide on the course of insulin-dependent diabetes mellitus].

Kretowski A, Kinalska I. Kretowski A, et al. Pol Arch Med Wewn. 1994 Aug;92(2):162-9. Pol Arch Med Wewn. 1994. PMID: 7800585 Review. Polish. No abstract available.

3

Iodine deficiency disorders in the north-eastern region of Poland (Białystok coordinating center).

Kinalska I, Borawski J, Kretowski A, Szelachowska M, Popławska A, Wysocka B. Kinalska I, et al. Among authors: kretowski a. Endokrynol Pol. 1993;44(3):297-304. Endokrynol Pol. 1993. PMID: 8055798

4

The increased activity of angiotensin-converting enzyme in patients with diabetes and nephropathy.

Szelachowska M, Kretowski A, Zdrojewicz Z. Szelachowska M, et al. Among authors: kretowski a. Horm Metab Res. 1996 May;28(5):250-1. doi: 10.1055/s-2007-979177. Horm Metab Res. 1996. PMID: 8738117 No abstract available.

5

Orally given nicotinamide inhibits the decreasing of glutathione content in the pancreas of streptozotocin diabetic rats.

Kretowski A, Szelachowska M, Górska M, Zendzian-Piotrowska M, Wysocka-Sołowie B, Kinalska I. Kretowski A, et al. Horm Metab Res. 1996 Jan;28(1):35-6. doi: 10.1055/s-2007-979127. Horm Metab Res. 1996. PMID: 8820993 No abstract available.

6

Increased in vitro interleukin-12 production by peripheral blood in high-risk IDDM first degree relatives.

Szelachowska M, Kretowski A, Kinalska I. Szelachowska M, et al. Among authors: kretowski a. Horm Metab Res. 1997 Apr;29(4):168-71. doi: 10.1055/s-2007-979014. Horm Metab Res. 1997. PMID: 9178025

7

Decreased in vitro IL-4 [corrected] and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I.

Szelachowska M, Kretowski A, Kinalska I. Szelachowska M, et al. Among authors: kretowski a. Horm Metab Res. 1998 Aug;30(8):526-30. doi: 10.1055/s-2007-978926. Horm Metab Res. 1998. PMID: 9761385

8

[Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].

Kretowski A, Szelachowska M, Kowalska I, Peczyńska J, Urban M, Kinalska I. Kretowski A, et al. Przegl Lek. 1998;55(6):315-9. Przegl Lek. 1998. PMID: 9857706 Clinical Trial. Polish.

9

CD23 antigen expression on B lymphocytes and soluble CD23 levels in peripheral blood of high-risk type 1 diabetes subjects.

Kretowski A, Szelachowska M, Pietruczuk M, Kinalska I. Kretowski A, et al. Scand J Immunol. 1999 Jan;49(1):78-81. doi: 10.1046/j.1365-3083.1999.00448.x. Scand J Immunol. 1999. PMID: 10023861 Free article.

10

Insulin increases in vitro production of Th2 profile cytokines in peripheral blood cultures in subjects at high risk of diabetes type 1 and patients with newly diagnosed IDDM.

Kretowski A, Myśliwiec J, Szelachowska M, Kinalski M, Kinalska I. Kretowski A, et al. Horm Metab Res. 1999 Apr;31(4):289-92. doi: 10.1055/s-2007-978736. Horm Metab Res. 1999. PMID: 10333088 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters